Covered recipient · General Payments record
KELSEY M KELLY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2025
$809.25
- Reported across 50 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.87 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $30.63 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.03 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.06 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.59 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.53 | 1 |
| Novo Nordisk AS | $17.34 | 1 |
| PFIZER INC. | $16.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.18 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206651071 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206270474 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.59 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225602142 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.53 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222924263 | CMS |
| Novartis Pharmaceuticals Corporation | $26.03 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200253470 | CMS |
| Novo Nordisk Inc | $17.34 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188632878 | CMS |
| PFIZER INC. | $16.69 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228893068 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.06 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250195509 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.